Rosen Law Firm Reminds Vistagen Therapeutics Investors of March 16 Lead Plaintiff Deadline

Rosen Law Firm is reminding investors who purchased Vistagen Therapeutics common stock between April 1, 2024 and December 16, 2025 of the March 16, 2026 lead plaintiff deadline. Investors may be entitled to compensation without paying fees or costs through a contingency fee arrangement. To join the class action, visit rosenlegal.com or call Phillip Kim toll-free at 866-767-3653. A class action lawsuit has already been filed, and investors who wish to serve as lead plaintiff must move the court by March 16, 2026.